Innovation and Investment Trends in the Niemann-Pick Disease Industry
Over the past decade, the pharmaceutical industry has demonstrated renewed dedication to addressing ultra-rare genetic conditions that were previously overlooked. Niemann-Pick Disease, a devastating group of lysosomal storage disorders, has emerged as a critical focus area for innovative therapeutic development. These conditions, characterized by abnormal accumulation of sphingomyelin and cholesterol within cellular structures, lead to…
